Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Financial Flexibility Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Financial Flexibility Index of 0.76x as of December 2024. Free cash flow of CN¥152.38 Million (operating CF CN¥47.07 Million minus capex CN¥105.31 Million) represents 1% of total liabilities (CN¥200.84 Million). Also explore Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Check Suzhou Fushilai Pharmaceutical Co. Ltd. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see Suzhou Fushilai Pharmaceutical Co. Ltd. stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.76x | CN¥152.38 Million | CN¥47.07 Million | CN¥200.84 Million | ▼ -5.2% |
| 2023 | 0.80x | CN¥136.39 Million | CN¥94.77 Million | CN¥170.45 Million | ▼ -15.8% |
| 2022 | 0.95x | CN¥201.30 Million | CN¥151.19 Million | CN¥211.75 Million | ▼ -22.9% |
| 2021 | 1.23x | CN¥280.48 Million | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.2% |
| 2020 | 1.40x | CN¥232.54 Million | CN¥166.85 Million | CN¥165.61 Million | ▲ +7.4% |
| 2019 | 1.31x | CN¥221.48 Million | CN¥150.55 Million | CN¥169.48 Million | — |